![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/c355a0b9-458b-4bbe-880e-f48e46e35db6/assets/images/medium/mbio.00099-22-f005.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/436f63da-2f4b-48a5-8830-b18e77712537/assets/images/medium/mbio.00099-22-f003.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![Carboxymethyl-kappa-carrageenan: A study of biocompatibility, antioxidant and antibacterial activities - ScienceDirect Carboxymethyl-kappa-carrageenan: A study of biocompatibility, antioxidant and antibacterial activities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S014181301940679X-ga1.jpg)